D-Pressin Spray contains an active component as Desmopressin. It also known as DDAVP (1-desamino-8-D-arginine vasopressin), is a synthetic form of the hormone vasopressin. Vasopressin is naturally produced in the body by the hypothalamus and released from the pituitary gland. It plays a crucial role in regulating water balance, blood pressure, and urine production.  D-Pressin Spray is the treatment of choice for central diabetes insipidus, a condition characterized by the inability of the body to properly regulate water balance. It helps reduce excessive thirst and urination by mimicking the action of vasopressin. It is sometimes used in the treatment of mild to moderate forms of VWD, a bleeding disorder caused by a deficiency or dysfunction of the von Willebrand factor. It stimulates the release of von Willebrand factor, which aids in clotting.

D-Pressin Spray can cause water retention, which may lead to a condition called hyponatremia (low sodium levels in the blood). It is important to monitor sodium levels during treatment, especially in individuals who are at an increased risk of hyponatremia, such as those with certain medical conditions or those taking medications that can affect sodium levels. This medication is primarily eliminated through the kidneys. Individuals with impaired kidney function may be at an increased risk of D-Pressin Spray accumulation and should be closely monitored while using the medication. If an individual has a known allergy or hypersensitivity to D-Pressin Spray or its components, its use should be avoided. Inform your healthcare provider about any pre-existing medical conditions, such as gastrointestinal disorders, liver disease, kidney disease, or other health conditions. These may require special precautions or adjustments in the use of this medication.

D-Pressin Spray is used to treat the following:

• Diabetes Insipidus
• Nocturnal Enuresis (Bedwetting)
• Von Willebrand Disease (VWD)

D-Pressin Spray is a medication that mimics the action of the hormone vasopressin in the body. Its therapeutic effect primarily focuses on regulating water balance and reducing excessive urine production. By increasing water reabsorption in the kidneys, it helps alleviate symptoms of conditions such as central diabetes insipidus and bedwetting (nocturnal enuresis). It can also aid in treating mild to moderate von Willebrand disease by promoting the release of von Willebrand factor, a clotting protein.

Inform the doctor about your medicines, including prescription, over-the-counter, nutritional or vitamin supplements, and herbal products. Certain medications may interact with D-Pressin Spray, reducing effectiveness by causing undesirable side effects.

• Store at room temperature, between 20°C to 25°C (68°F to 77°F).
• Keep away from moisture, heat, and light.
• It should not be frozen.
• Keep away from children and pets.

D-Pressin Spray can be administered orally in tablet form, as a nasal spray, or through injection. The specific usage instructions may vary depending on the condition being treated and the form of the medication. The nasal spray is administered by spraying into the nostrils, alternating nostrils with each dose.

D-Pressin Spray cause some side effects like all medications, although not everyone will experience them. 

Serious:

• Severe allergic reactions, including rash, itching, swelling, severe dizziness, or difficulty breathing
• Hyponatremia (low sodium levels)
• Fluid overload
• Severe headache or migraine

Common:

• Headache
• Nausea
• Stomach pain or cramps
• Flushing (redness or warmth of the skin)
• Nasal congestion or irritation (when using the nasal spray form)
• Runny nose or sneezing (when using the nasal spray form)

Advice regarding D-Pressin Spray is to always consult with a healthcare professional before starting or making any changes to your medication regimen. They can assess your medical history, evaluate potential risks and benefits, provide personalized guidance, and monitor your progress throughout treatment. Additionally, closely follow the instructions and recommendations your healthcare provider gives, promptly report any unusual or concerning symptoms, and communicate openly about any concerns or questions you may have. Precautions should be taken when using this medication in patients with liver or kidney impairment, as dosage adjustments or special monitoring may be required. Pregnant and breastfeeding individuals should consult with healthcare professionals before using this medication. Your healthcare professional is the best resource for ensuring safe and effective medication use.

1. Aspire Pharma; Electronic Medicines Compendium; [Revised: 2020] [Accesses: 17/July/2023]; https://www.medicines.org.uk/emc/files/pil.11939.pdf
2. Ferring Pharmaceuticals Ltd; Electronic Medicines Compendium; [Revised:2020] [Accessed: 17/July/2023]; https://www.medicines.org.uk/emc/product/3795/pil
3. TS McCarty, Shah AD; Desmopressin; NCBI Bookshelf; [Revised:2020] [Accessed:17/July/2023] ; https://www.ncbi.nlm.nih.gov/books/NBK554582/
4. Johan Vande Walle et al; Desmopressin 30 years in clinical use: A safety review; [Revised: 2007] [Accessed: 17/July/2023] ; https://pubmed.ncbi.nlm.nih.gov/18690973/